Your institution may have access to this item. Find your institution then sign in to continue.
Title
Sodium-glucose cotransporter 2 inhibitors in type 1 diabetes: a missed opportunity for cardiovascular protection? SGLT2 inhibitors show promise in improving metabolic and cardiovascular health in type 1 diabetes, yet ideal candidates for therapy require careful selection